Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) Stock Price, Quote & AI Analysis
Live RVPH stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Reviva Pharmaceuticals Holdings, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Reviva Pharmaceuticals Holdings, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Reviva Pharmaceuticals Holdings, Inc. Common Stock Overview
Company information
Company Overview
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Reviva Pharmaceuticals Holdings, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...